Orqueda, A. J., Dansey, M. V., Español, A. J., Veleiro, A. S., Burton, G., & Pecci, A. (2014). The rigid steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) is a dissociated glucocorticoid receptor modulator potentially useful as a novel coadjuvant in breast cancer chemotherapy.
Cita Chicago Style (17a ed.)Orqueda, Andrés Javier, Maria Virginia Dansey, Alejandro Javier Español, Adriana Silvia Veleiro, Gerardo Burton, y Adali Pecci. The Rigid Steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) Is a Dissociated Glucocorticoid Receptor Modulator Potentially Useful as a Novel Coadjuvant in Breast Cancer Chemotherapy. 2014.
Cita MLA (8a ed.)Orqueda, Andrés Javier, et al. The Rigid Steroid 21-hydroxy-6,19-epoxyprogesterone (21OH-6,19OP) Is a Dissociated Glucocorticoid Receptor Modulator Potentially Useful as a Novel Coadjuvant in Breast Cancer Chemotherapy. 2014.